Source: International Congress 2016 – Pharmacological management of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Robert A Wise (Baltimore, United States of America), Robert A. Wise, Antonio Anzueto, Achim Mueller, Norbert Metzdorf, Peter M.A. Calverley. Tiotropium in chronic obstructive pulmonary disease: Gender differences in outcomes. Eur Respir J 2016; 48: Suppl. 60, 298

Member's Comments

No comment yet.

Related content which might interest you: The CANT score: Predicting mortality in exacerbations of chronic obstructive pulmonary disease Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016 Acute exacerbations of chronic obstructive pulmonary disease: Is it acute exacerbations of chronic cardiopulmonary disease? Source: International Congress 2014 – Comorbidities Year: 2014 Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Nutritional status in chronic obstructive pulmonary disease Source: International Congress 2014 – Comorbidities Year: 2014 Relationship between dyspnea and depression in the elderly patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD: points to ponder Year: 2014 Assessing COPD profiles and outcomes by dyspnoea severity Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Comparison of patient-reported outcomes (PROs) during acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD: points to ponder Year: 2014 Obesity and impairments in chronic obstruction pulmonary disease (COPD) Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Relevance of hemoglobin A1c and acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Some gender features of the chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD treatment Year: 2013 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Tiotropium in the management of chronic obstructive pulmonary disease Source: Eur Respir J 2002; 19: 205-206 Year: 2002 Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016